Membrane News and Research

RSS

Sunshine Biopharma completes Adva-27a cytotoxicity study in Multidrug Resistant Breast Cancer cell line

Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.

11 Jul 2011

Scientists probe 'atlastin,' a protein linked to hereditary spastic paraplegia

New research from Rice University and Italy's Eugenio Medea Scientific Institute is yielding clues about hereditary spastic paraplegia (HSP), a group of inherited neurological disorders that affect about 20,000 people in the United States.

11 Jul 2011

New technique may help scientists probe mysteries of many different stem cells

Researchers at the Salk Institute have been able to genetically incorporate "unnatural" amino acids, such as those emitting green fluorescence, into neural stem cells, which then differentiate into brain neurons with the incandescent "tag" intact.

8 Jul 2011

Final Atlantis space trip may open new era of research into infectious diseases

On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State University's Biodesign Institute.

7 Jul 2011

Nanoscientist to develop new microsystem for more efficient drug-testing

A University of Southampton nanoscientist is working on a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.

6 Jul 2011

New technique explores how cells react to rapidly changing patterns of chemoattractants

Many cell types in higher organisms are capable of implementing directed motion in response to the presence of certain chemical attractants in their vicinity. A team led by Dr. Doris Heinrich of the Faculty of Physics and the Center for NanoScience (CeNS) at Ludwig-Maximilians-Universit-t (LMU) in Munich has developed a novel technique to expose an ensemble of living cells to rapidly varying concentrations of chemoattractants.

6 Jul 2011

UVA biologists discover new information about how Ebola virus works

Molecular and cell biologists at the University of Virginia Health System have discovered new information about how the Ebola virus works that could eventually lead to new drug treatments for the deadly virus.

6 Jul 2011

Smart nanomaterials can disrupt blood supply to cancerous tumours

Scientists at the University of Southampton have developed smart nanomaterials, which can disrupt the blood supply to cancerous tumours.

5 Jul 2011

Novel drug delivery device can treat diabetes-related retinal damage

A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes.

1 Jul 2011

Recombinant attenuated Salmonella vaccines hold promise against infectious diseases

A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia.

30 Jun 2011

Protect your ears from loud noise of fireworks, trains, and concerts

The sounds of summer can be noisy. "Fireworks, trains, concerts and road construction can be harmful to your hearing. And once hearing is damaged, it cannot be repaired," said Jyoti Bhayani, certified audiologist at Gottlieb Memorial Hospital, part of Loyola University Health System.

30 Jun 2011

Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for children

A cellulose powder has been used increasingly for many years against allergic rhinitis. Still, there has been a shortage of scientific evidence for its efficacy in seasonal allergic rhinitis (hay fever), particularly in children. Now, however, scientists from the Sahlgrenska Academy and the Department of Plant and Environmental Sciences at the University of Gothenburg have proven that the cellulose powder reduces symptoms of seasonal allergic rhinitis in children, without any adverse effects.

29 Jun 2011

Sandia receives four R&D Magazine's 2011 awards

Sandia National Laboratories researchers - competing in an international pool of universities, corporations and government labs - captured three prestigious R&D 100 Awards in this year's contest, and were cowinners of a fourth.

23 Jun 2011

New surprising details about flow of neurotransmitters between brain neurons

Two studies featuring research from Weill Cornell Medical College have uncovered surprising details about the complex process that leads to the flow of neurotransmitters between brain neurons -- a dance of chemical messages so delicate that missteps often lead to neurological dysfunction.

23 Jun 2011

Molecularly targeted glue for cancer

"This is a totally new approach to cancer therapy," says Professor Patrick Gunning of the Department of Chemical and Physical Sciences. "Everything prior to this has targeted functionally relevant binding sites. Our approach inhibits the mobility of cancer-promoting proteins within cells-essentially, it's like molecularly targeted glue."

23 Jun 2011

Two NJIT researchers receive U.S. Patent for nanoprobe array technique

Reginald C. Farrow and Zafer Iqbal, research professors at NJIT, were awarded a patent today for an improved method of fabricating arrays of nanoscale electrical probes. Their discovery may lead to improved diagnostic tools for measuring the spatial variation of electrical activity inside biological cells.

22 Jun 2011

Experts to discuss science and clinical management of vasospasm at Cincinnati conference

Cerebrovascular experts from around the world will gather in Cincinnati next month to discuss the science and clinical management of vasospasm, a dreaded, life-threatening complication of subarachnoid hemorrhage, while working toward an ambitious goal.

22 Jun 2011

Novel method of disguising nanoparticles as red blood cells to fight cancer

Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body's immune system and deliver cancer-fighting drugs straight to a tumor. Their research was published this week in the online Early Edition of the Proceedings of the National Academy of Sciences.

22 Jun 2011

Scientists discover linchpin protein that drives mitochondria's calcium machinery

Mitochondria, those battery-pack organelles that fuel the energy of almost every living cell, have an insatiable appetite for calcium. Whether in a dish or a living organism, the mitochondria of most organisms eagerly absorb this chemical compound.

20 Jun 2011

Scientists discover three susceptibility genes for development of progressive supranuclear palsy

An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.

20 Jun 2011

Membrane News and Research

Sunshine Biopharma completes Adva-27a cytotoxicity study in Multidrug Resistant Breast Cancer cell line

Scientists probe 'atlastin,' a protein linked to hereditary spastic paraplegia

New technique may help scientists probe mysteries of many different stem cells

Final Atlantis space trip may open new era of research into infectious diseases

Nanoscientist to develop new microsystem for more efficient drug-testing

New technique explores how cells react to rapidly changing patterns of chemoattractants

UVA biologists discover new information about how Ebola virus works

Smart nanomaterials can disrupt blood supply to cancerous tumours

Novel drug delivery device can treat diabetes-related retinal damage

Recombinant attenuated Salmonella vaccines hold promise against infectious diseases

Protect your ears from loud noise of fireworks, trains, and concerts

Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for children

Sandia receives four R&D Magazine's 2011 awards

New surprising details about flow of neurotransmitters between brain neurons

Molecularly targeted glue for cancer

Two NJIT researchers receive U.S. Patent for nanoprobe array technique

Experts to discuss science and clinical management of vasospasm at Cincinnati conference

Novel method of disguising nanoparticles as red blood cells to fight cancer

Scientists discover linchpin protein that drives mitochondria's calcium machinery

Scientists discover three susceptibility genes for development of progressive supranuclear palsy

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News